Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-10-25
|
pubmed:abstractText |
The results of autologous and allogeneic BMT in 44 patients with Hodgkin's or non-Hodgkin's lymphomas who received preparative therapy consisting of busulfan 16 mg/kg and cyclophosphamide 120 mg/kg are presented. Sixteen patients are surviving free of disease between 8 months and 6 years after transplantation. Thirteen patients either did not attain complete remission or experienced a recurrence of their disease. Fifteen patients died from treatment-related complications. Karnofsky score < or = 70, lactate dehydrogenase greater than twice normal and the development of hepatic veno-occlusive disease were associated with failure to achieve lymphoma-free survival.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
133-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8401359-Adolescent,
pubmed-meshheading:8401359-Adult,
pubmed-meshheading:8401359-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8401359-Busulfan,
pubmed-meshheading:8401359-Combined Modality Therapy,
pubmed-meshheading:8401359-Cyclophosphamide,
pubmed-meshheading:8401359-Female,
pubmed-meshheading:8401359-Hodgkin Disease,
pubmed-meshheading:8401359-Humans,
pubmed-meshheading:8401359-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8401359-Male,
pubmed-meshheading:8401359-Middle Aged,
pubmed-meshheading:8401359-Prognosis,
pubmed-meshheading:8401359-Survival Rate,
pubmed-meshheading:8401359-Treatment Outcome
|
pubmed:year |
1993
|
pubmed:articleTitle |
Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY.
|
pubmed:affiliation |
Arthur G. James Cancer Hospital and Research Institute, Ohio State University, Columbus.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|